Enhanced

Cash

GIM’s disciplined approach to fixed income management is long term and risk averse. GIM seeks to deliver attractive risk-adjusted returns by constructing diversified portfolios that have the potential to provide price stability during periods of interest rate volatility.

Highlights

  • Investment process guided by diversification, liquidity and low risk
  • Benchmarked to the Merrill Lynch 1-3 Year Treasury/ Agency
  • Focuses on shorter maturities and seeks to avoid exposure to the long end of the market
  • Inception date of December 31, 2001

Portfolio Managers

  • Stephen J. Mahoney

    Portfolio Manager, Taxable Fixed Income
 
As of 3/31/2021 QTD YTD 1 YEAR 3 YEAR 5 YEAR 10 YEAR Since Inception Inception Date
Glenmede Enhanced Cash (Gross) -0.3% -0.3% 1.8% 2.7% 1.9% 1.5% 2.5% 12/31/2001
Glenmede Enhanced Cash (Net) -0.4% -0.4% 1.4% 2.3% 1.5% 1.1% 2.1%  
Merrill Lynch 1-3 Yr Treasury/Agency 0.0% 0.0% 0.3% 2.8% 1.7% 1.3% 2.3%  

Calendar Year Returns

  Glenmede Gross Glenmede Net Merrill Lynch 1-3 Yr Treasury/Agency Gross +/-
2020 2.7% 2.3% 3.1% -0.4%
2019 3.9% 3.4% 3.5% 0.4%
2018 1.7% 1.3% 1.6% 0.1%
2017 1.2% 0.8% 0.4% 0.8%
2016 1.3% 0.9% 0.9% 0.4%
2015 0.8% 0.4% 0.6% 02.%
2014 0.8% 0.4% 0.6% 0.1%
2013 0.6% 0.2% 0.4% 0.2%
2012 0.9% 0.5% 0.5% 0.4%
2011 1.7% 1.3% 1.6% 0.2%
2010 2.5% 2.1% 2.3% 0.2%
2009 2.1% 1.7% 1.2% 0.9%
2008 4.9% 4.5% 6.8% -1.9%
2007 5.7% 5.3% 7.1% -1.4%
2006 4.7% 4.3% 4.1% 0.6%
2005 2.1% 1.7% 1.7% 0.4%
2004 1.3% 0.9% 1.0% 0.3%
2003 2.5% 2.1% 2.0% 0.5%

 

 

This website is for informational purposes only and is not a solicitation for any product or service.  GIM products are actively managed and their characteristics will vary.  All investment has risk, including the risk of loss of principal.  There can be no assurance that efforts to manage risk or to achieve any articulated investment objective will be successful.  An investor should consider investment objectives, risks, charges and expenses carefully before investing. For additional information regarding risks and about the firm, please refer to Related Literature and Disclosures.